fenoldopam has been researched along with Alveolitis, Fibrosing in 1 studies
Fenoldopam: A dopamine D1 receptor agonist that is used as an antihypertensive agent. It lowers blood pressure through arteriolar vasodilation.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Idiopathic pulmonary fibrosis (IPF) is the most common fatal interstitial lung disease, with limited therapeutic options." | 1.62 | Dopamine receptor agonists ameliorate bleomycin-induced pulmonary fibrosis by repressing fibroblast differentiation and proliferation. ( Liu, J; Miao, K; Mou, Y; Pan, T; Wang, Q; Xiong, W; Xu, Y; Yu, J, 2021) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Mou, Y | 1 |
| Liu, J | 1 |
| Pan, T | 1 |
| Wang, Q | 1 |
| Miao, K | 1 |
| Xu, Y | 1 |
| Xiong, W | 1 |
| Yu, J | 1 |
1 other study available for fenoldopam and Alveolitis, Fibrosing
| Article | Year |
|---|---|
Dopamine receptor agonists ameliorate bleomycin-induced pulmonary fibrosis by repressing fibroblast differentiation and proliferation.
Topics: Animals; Antibiotics, Antineoplastic; Benzimidazoles; Bleomycin; Cell Differentiation; Cell Prolifer | 2021 |